High Mark Wealth Management LLC Pliant Therapeutics, Inc. Transaction History
High Mark Wealth Management LLC
- $217 Million
- Q3 2025
A detailed history of High Mark Wealth Management LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 219,000 shares of PLRX stock, worth $378,870. This represents 0.15% of its overall portfolio holdings.
Number of Shares
219,000
Previous 141,000
55.32%
Holding current value
$378,870
Previous $163,000
98.77%
% of portfolio
0.15%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding PLRX
# of Institutions
113Shares Held
58.9MCall Options Held
209KPut Options Held
102K-
Tang Capital Management LLC San Diego, CA6MShares$10.4 Million0.4% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.5MShares$7.79 Million0.03% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.34MShares$7.51 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.51MShares$6.07 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $84.2M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...